Image 1 of 1
Image 1 of 1
Image 1 of 1
Image 1 of 1
Retatrutide is an investigational multi-receptor agonist peptide designed to target metabolic signaling pathways. It acts on GLP-1, GIP, and glucagon receptors, making it part of a newer class of triple-hormone receptor agonists under clinical development for metabolic research.
Unlike single-pathway agents, retatrutide is engineered to influence multiple mechanisms involved in glucose regulation, appetite signaling, and energy expenditure.
Retatrutide is an investigational multi-receptor agonist peptide designed to target metabolic signaling pathways. It acts on GLP-1, GIP, and glucagon receptors, making it part of a newer class of triple-hormone receptor agonists under clinical development for metabolic research.
Unlike single-pathway agents, retatrutide is engineered to influence multiple mechanisms involved in glucose regulation, appetite signaling, and energy expenditure.